Kenvue (Kenvue) Risk Assessment

View and export this data going back to 2023. Start your Free Trial

What is Kenvue Risk Assessment?

Risk Assessment represents the investment risk of a stock derived from our exclusive method. It suggests how risky the investment opportunity is based on the valuation and the fundamental performance of the stock. It is derived from following key aspects:

1. GuruFocus internally developed valuations of the stock, such as GF valuation.
2. Quality Rank, a business quality indicator developed by GuruFocus.
3. Fundamental performance: Piotroski F-Score, Altman Z-Score, Beneish M-Score, etc.
4. Growth opportunities: 5-year revenue growth rate, 5-Year EPS without NRI Growth Rate, etc.

Value investors are always willing to find undervalued stocks. However, not all the undervalued stocks are good deals, we should also be careful of how risky the investment opportunity is. We believe that if the company's financial strength and profitability are strong, and the stock price is within a reasonable range of the GF valuation, or stock has a high return with its price being undervalued, then it might be a good investment opportunity with low risk.

Based on those aspects listed above, GuruFocus believes the risk assessment of Kenvue is: No Data: Cannot be evaluated.

Competitive Comparison of Kenvue's Risk Assessment

For the Household & Personal Products subindustry, Kenvue's Risk Assessment, along with its competitors' market caps and Risk Assessment data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Kenvue's Risk Assessment Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Kenvue's Risk Assessment distribution charts can be found below:

* The bar in red indicates where Kenvue's Risk Assessment falls into.

Kenvue (NYSE:KVUE) Risk Assessment Explanation

Based on the four aspects listed above, GuruFocus provides the following 7 evaluations:

All-in-One Screener Examples (1)
Low Risk: Strong fundamentals, worth long-term holding
Moderate Risk: Sensitive, better choose undervalued stock
High Risk: High uncertainty with risk-return tradeoff
High Risk: Good fundamentals, beware of shrinking business
High Risk: Sensitive to economic or industry trends
High Risk: High uncertainty
No Data: Cannot be evaluated

(1) These are some simple examples. You can access our Risk Assessment filter under All-in-One Screener’s Fundamental tab and set your own criteria.

Kenvue Risk Assessment Related Terms

Thank you for viewing the detailed overview of Kenvue's Risk Assessment provided by GuruFocus.com. Please click on the following links to see related term pages.

Kenvue (Kenvue) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Kenvue Inc (NYSE:KVUE) » Definitions » Risk Assessment

Comparable Companies

Traded in Other Exchanges

J4D:Germany J4D:Germany J4D:Germany

Address

199 Grandview Road, Skillman, NJ, USA, 08558

Website

https://www.kenvue.com

Kenvue is the world's largest pure-play consumer health company by sales, generating $15 billion in annual revenue. Formerly known as Johnson & Johnson's consumer segment, Kenvue spun off and went public in May 2023. It operates in a variety of silos within consumer health, such as cough, cold and allergy care, pain management, face and body care, and oral care, as well as women's health. Its portfolio includes a wide array of some of the most well-known brands in the space, including Tylenol, Listerine, Johnson's, Aveeno, and Neutrogena. Despite playing in a fragmented industry with intense competition and ever-changing consumer preferences, many of Kenvue's brands are the global leader in their respective segment thanks to their strong brand power.

Executives

Allison Richard E Jr	director	30 FRANK LLOYD WRIGHT DR, ANN ARBOR MI 48105
Seemantini Godbole	director	1000 LOWE'S BOULEVARD, MOORESVILLE NC 28117
Bing Xie	officer: Group President, Asia Pacific	199 GRANDVIEW ROAD, SKILLMAN NJ 08558
Donna Lorenson	officer: Chief Corp Affairs Officer	199 GRANDVIEW ROAD, SKILLMAN NJ 08558
Matthew Orlando	officer: General Counsel	199 GRANDVIEW ROAD, SKILLMAN NJ 08558
Luani Alvarado	officer: Chief People Officer	199 GRANDVIEW ROAD, SKILLMAN NJ 08558
Jan Meurer	officer: Chief Growth Officer	199 GRANDVIEW ROAD, SKILLMAN NJ 08558
Carlton Lawson	officer: Group President, EMEA	199 GRANDVIEW ROAD, SKILLMAN NJ 08558
Caroline Tillett	officer: Chief Scientific Officer	199 GRANDVIEW ROAD, SKILLMAN NJ 08558
Bernardo Tavares	officer: Chief Tech & Data Officer	199 GRANDVIEW ROAD, SKILLMAN NJ 08558
Tamara Franklin	director	107 STONE CLIFF ROAD, PRINCETON NJ 08540
Betsy D Holden	director	DENTSPLY SIRONA INC, 13320 BALLANTYNE CORPORATE PLACE, CHARLOTTE NC 28277
Kathy Widmer	officer: Group President, NALA	C/O ELIZABETH ARDEN, INC., 2400 S.W. 145 AVENUE, MIRAMAR FL 33027
Michael E Sneed	director	JOHNSON & JOHNSON, ONE JOHNSON & JOHNSON PLAZA, NEW BRUNSWICK NJ 08933
Joseph J Wolk	director	JOHNSON & JOHNSON, ONE JOHNSON & JOHNSON PLAZA, NEW BRUNSWICK NJ 08933